Reactive oral cholera vaccination reduced transmission by 53.5% to 62.1% in Blantyre, Malawi.
This observational case study evaluated the effectiveness of a reactive oral cholera vaccine (OCV) campaign during a cholera outbreak in Blantyre District, Malawi. The outbreak predominantly affected middle-aged men in urban areas, with data collected from late November 2022 through April 2023. The intervention involved the implementation of the OCV campaign, compared against the period prior to its rollout. Routine surveillance data were utilized to estimate vaccine effectiveness, acknowledging that individual-level data were frequently incomplete due to infrastructure and resource constraints.
Primary analysis revealed an unadjusted vaccine-associated reduction in transmission of 53.52% (95% CrI: 42.5-64.1%). When adjusted for the 7-day rolling average of water, sanitation, and hygiene (WASH) activity, the estimated vaccine effectiveness increased to 62.1% (95% CrI: 49.3-74.9%). The analysis examined the time-varying reproduction number (Rt) and interaction effects with WASH interventions. No adverse events, serious adverse events, discontinuations, or tolerability issues were reported, though specific safety data were not detailed in the source text.
Key limitations include the short time frames of vaccination campaigns and the incompleteness of individual-level data inherent to the outbreak setting. The study design precludes definitive causal inference, as classical observational designs are not feasible during such outbreaks. Uncertainty was propagated through posterior sampling. Despite these constraints, the results provide actionable evidence for policymakers regarding outbreak response in resource-limited settings, highlighting the potential role of OCV in reducing transmission alongside WASH efforts.